Topical onychomycosis treatment product clenafin® topical solution 10%

Abstract

CLENAFIN® topical solution 10 % is the country’s first topical treatment for onychomycosis, launched in Japan in September 2014. CLENAFIN® contains efinaconazole, novel triazole antifungal drug as its active ingredient. Efinaconazole does not bind well with keratin, the main component of nails, meaning that this drug has superior nail penetrating properties. CLENAFIN® has proven effective in treating onychomycosis through once-daily application to the infected nails. CLENAFIN® comes packaged in a bottle with a connected brush, making it easy to apply the drug across the surface of nails.